Education
About Us
Working with TipRanks
Follow Us
P3 Health Partners (PIII)
NASDAQ:PIII
Total Valuation
P3 Health Partners has a market cap or net worth of $60.81M. The enterprise value is $216.69M.
Market Cap$60.81M
Enterprise Value$216.69M
Share Statistics
P3 Health Partners has 3,268,218 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,268,218
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
P3 Health Partners’s return on equity (ROE) is -1.79 and return on invested capital (ROIC) is -92.40%.
Return on Equity (ROE)-1.79
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-92.40%
Return on Capital Employed (ROCE)-1.12
Revenue Per Employee4.17M
Profits Per Employee-862.16K
Employee Count360
Asset Turnover1.92
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of P3 Health Partners is ―. P3 Health Partners’s PEG ratio is -0.00448.
PE Ratio―
PS Ratio0.02
PB Ratio0.43
Price to Fair Value0.43
Price to FCF-0.30
Price to Operating Cash Flow-0.21
PEG Ratio-0.00448
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.50B and earned -135.85M in profits. Earnings per share was -46.79.
Revenue1.50B
Gross Profit1.50B
Operating Income-320.66M
Pretax Income-305.99M
Net Income-135.85M
EBITDA-197.76M
Earnings Per Share (EPS)-46.79
Cash Flow
In the last 12 months, operating cash flow was -122.75M and capital expenditures -119.00K, giving a free cash flow of -122.87M billion.
Operating Cash Flow-122.75M
Free Cash Flow-122.87M
Free Cash Flow per Share-37.59
Dividends & Yields
P3 Health Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-55.36%
50-Day Moving Average8.10
200-Day Moving Average7.99
Relative Strength Index (RSI)24.03
Average Volume (3m)7.40K
Important Dates
P3 Health Partners upcoming earnings date is Mar 26, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
P3 Health Partners as a current ratio of 0.37, with Debt / Equity ratio of -271.14%
Current Ratio0.37
Quick Ratio0.37
Debt to Market Cap4.74
Net Debt to EBITDA-0.64
Interest Coverage Ratio-14.46
Taxes
In the past 12 months, P3 Health Partners has paid 4.39M in taxes.
Income Tax4.39M
Effective Tax Rate-0.01
Enterprise Valuation
P3 Health Partners EV to EBITDA ratio is -0.81, with an EV/FCF ratio of -1.45.
EV to Sales0.11
EV to EBITDA-0.81
EV to Free Cash Flow-1.45
EV to Operating Cash Flow-1.45
Balance Sheet
P3 Health Partners has $37.71M in cash and marketable securities with $50.66M in debt, giving a net cash position of -$12.95M billion.
Cash & Marketable Securities$37.71M
Total Debt$50.66M
Net Cash-$12.95M
Net Cash Per Share-$3.96
Tangible Book Value Per Share-$146.29
Margins
Gross margin is -3.33%, with operating margin of -21.37%, and net profit margin of -9.05%.
Gross Margin-3.33%
Operating Margin-21.37%
Pretax Margin-20.39%
Net Profit Margin-9.05%
EBITDA Margin-13.18%
EBIT Margin-18.92%
Analyst Forecast
The average price target for P3 Health Partners is $10.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.25
Price Target Upside92.31% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-2.15%
EPS Growth Forecast-6.72%